Micro-dosing Psilocybin Mushrooms improve mental health after one month.
Suffering from mental health issues for over 30 years now and being prescribed the same medication year in and year out without any significant improvement one must look at alternative ways to heal.
I suffer from anxiety, stress, depression, panic attacks, social disconnection, and OCD.
The NHS has failed me because month after month my symptoms do not improve, and I must resort to self-help to get through certain days.
I have never explored or ever taken psychedelic drugs and it was only by watching a documentary on Netflix “How to change your mind” that I started to realize there are diverse ways to treat my disorder.
Psilocybin Mushrooms.
Psilocybin mushrooms: commonly known as magic mushrooms, mushrooms, are a polyphyletic informal group of fungi that contain psilocybin which turns into psilocin upon ingestion. Biological genera containing psilocybin mushrooms include Copelandia, Gymnopilus, Inocybe, Panaeolus, Pholiotina, Pluteus, and Psilocybe. Wikipedia
The study published in Nature: Scientific Reports has observed significant benefits to mood and mental health after one month of micro-dosing psilocybin mushrooms.
Mushroom microdoses saw greater improvements across the DASS domains of Depression, Anxiety, and Stress. The study found that the microdose cognitive efficacy was higher performing in people aged under 55.
The study looked at 1133 people over the course of two years. All subjects were over 18 years old, able to read in English, and had access to an iPhone iOS device where participants recorded their results. Scientific Reports is a peer-reviewed, open-access scientific journal published online by Nature Portfolio.
The study was conducted by a team of experts in the fields of psychology and mycology: Joseph M. Rootman, Department of Psychology, University of British Columbia, Kelowna, BC, Canada; Maggie Kiraga, an employee of Quantified Citizen Technologies. Pamela Kryskow, a member of the clinical advisory board of Numinus Wellness, co-founder of MycoMedica Life Sciences, and on the Scientific & Medical Advisory Board; Kalin Harvey; Paul Stamets, who founded Fungi Perfecti, LLC; Eesmyal Santos-Brault; Kim P. C. Kuypers; and Zach Walsh, a member of the Advisory Board of the Multidisciplinary Association for Psychedelic Studies (MAPS) Canada and MycoMedica Life Sciences.
The reason GPs are not willing to advise or prescribe holistic medicine is that it would cost the Big Pharma Industry big bucks. If people could cure themselves after a month of using natural plant-made drugs the pharma companies would soon feel the pinch. I wrote previously what your doctor won’t tell you.
I have concluded my own doctor is as useful as a chocolate fire guard.
Even if my doctor could not prescribe ‘Microdosing Psilocybin Mushrooms’ she could have at least told me about it and recommended where I should go to get it. According to the UK, it is still not legal and a petition was made but coincidently because of a General Election in November 2019 it was closed, well all I can say is someone should restart it again: https://petition.parliament.uk/archived/petitions/260806
All I know is that Imperial College London is doing research into the benefits and negative effects of psilocybin and other psychedelic compounds. I only say this as I reside in the UK but other parts of the world will have other studies, where you need to do your own research to find out who is doing it closer to your area.
In the most rigorous trial to date assessing the therapeutic potential of a ‘psychedelic’ compound, researchers compared two sessions of psilocybin therapy with a six-week course of a leading antidepressant (a selective serotonin reuptake inhibitor called escitalopram) in 59 people with moderate-to-severe depression.
The results, published today in the New England Journal of Medicine, show that while depression scores were reduced in both groups, the reductions occurred more quickly in the psilocybin group and were greater in magnitude.
Editors Thoughts.
As a consequence, I blame the NHS and the powers that be for not giving me the right support and ultimately making my condition worse.
Similar to abortions, who has the right to say what you do with your body?
It is your body and how you treat is your business and no one else’s unless you are out of control.
What a person consumes is on them if they are of sound mind. Why make alcohol and cigarettes legal when they cause, liver failure or cancer. The reason why is because ‘Big Pharma’ relies on you becoming unwell. Whilst if everyone was cured they would not be laughing all the way to the bank.
The Journal of Psychopharmacology published a follow-up earlier this year to this widely-publicized study from Johns Hopkins Medicine that found psilocybin may continue to help people with depression up to one year later.
People treated with psilocybin – named ‘COMP360’ by its developers, COMPASS Pathways PLC – showed marked improvements across a range of subjective measures, including in their ability to feel pleasure, and express emotions, greater reductions in anxiety and suicidal ideation, and increased feelings of wellbeing.
Dr. Robin Carhart-Harris, Head of the Centre for Psychedelic Research at Imperial, who designed and led the study, said: “These results comparing two doses of psilocybin therapy with 43 daily doses of one of the best performing SSRI antidepressants help contextualize psilocybin’s promise as a potential mental health treatment. Remission rates were twice as high in the psilocybin group than in the escitalopram group.
“One of the most important aspects of this work is that people can clearly see the promise of properly delivered psilocybin therapy by viewing it compared with a more familiar, established treatment in the same study. Psilocybin performed very favorably in this head-to-head.”
https://www.imperial.ac.uk/news/219413/magic-mushroom-compound-performs-well-antidepressant/
As suggested by the Imperial College London / Thomas Angus; Psilocybin capsules: warn that while the initial findings are encouraging, patients with depression should not attempt to self-medicate with psilocybin. However, I will be writing to anyone that is doing clinical trials with the view of volunteering.
I am therefore going to be on the lookout for clinical trials in my area, we can only wait and see. I could have been cured years ago, instead of being kept as a lab rat.
#magicmushroons #microdosing #psilocybinmushrooms #psychedelics
The Editor Suffers From OCD & Cerebellar Atrophy. She is an Entrepreneur & Published Author, she writes content on a range of topics, including politics, current affairs, health and business. She is an advocate for Mental Health, Human Rights & Disability Discrimination.
Whilst her disabilities can be challenging she has adapted her life around her health and documents her journey online.
Disabled Entrepreneur - Disability UK Online Journal Offers Digital Marketing, Content Writing, Website Creation, SEO, and Domain Brokering. Disabled Entrepreneur - Disability UK is an open platform that invites contributors to write articles and serves as a dynamic marketplace where a diverse range of talents and offerings can converge. This platform acts as a collaborative space where individuals or businesses can share their expertise, creativity, and products with a broader audience.
